Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice

Endocrinology

Volumn 142, Issue 5, 2001, Pages 1958-1967

  Modric, Tomislav ^a,c   Silha, Josef V ^a   Shi, Zengdun ^a   Gui, Yaoting ^a   Suwanichkul, Adisak ^b   Durham, Susan K ^b   Powell, David R ^b   Murphy, Liam J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PHOSPHOGLYCERATE KINASE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY WEIGHT; BRAIN WEIGHT; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE EXPRESSION; HEART; INTRAUTERINE GROWTH RETARDATION; KIDNEY; KIDNEY MASS; NONHUMAN; OBESITY; PHENOTYPE; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEANING;

EID: 0035043176     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.5.8165     Document Type: Article

References (37)

1. Insulin-like growth factor binding proteins in the human circulation: A review
2. Growth hormone dependent insulin like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human fibroblasts
3. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF-I action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity
4. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I
5. An acid-stable insulin like growth factor (IGF)-binding protein from pig serum inhibits binding of IGF-I and IGF-II to vascular endothelial cells
6. Structural and biological characterization of bovine insulin-like growth factor binding protein-3
7. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: Stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol
8. IGF-I induced IGFBP-3 potentiates the mitogenic actions of IGF-I in mammary epithelial MD-IGF-I cells
9. Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: Control of IGF signalling to bone cells by IGFBP-3-specific proteolysis?
10. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells
11. The human insulin-like growth factor (IF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene
12. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin
13. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3
14. Insulin-like growth factor-binding protein-3 binds fibrogen and fibrin
15. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3
16. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism
17. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
18. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor
19. Insulin-like growth factor (IGF)-binding proteins in serum-do they have additional roles besides modulating the endocrine IGF actions?
20. Optimization of plasmid vectors for high-level expression in lung epithelial cells
21. Neonatal lethality and lymphoperua in mice with a homozygous disruption of the c-abl proto-oncogene
22. The variability in activity of the universally expressed human cytomegalovirus major immediate early gene 1 enhancer/promoter in transgeruc mice
23. High-level and erthyroid-specific expression of human glucose-6-phosphate dehydrogenase in transgenic mice
24. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
25. Strain-specific differences in mouse wound healing are mediated by divergent T helper cytokine responses
26. Formation of 150-kDa binary complexes of insulin-like growth factor binding protein-3 and the acid-labile subunit in vitro and in vivo
27. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice
28. Normal growth and development in the absence of hepatic insulin-like growth factor I
29. The relative importance of endocrine versus autocrine/paracrine insulin-like growth factor-I in tee regulation of body growth
30. Acute regulation of insulin-like growth factor-I gene expression by growth hormone during adipose cell differentiation
31. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes
32. Differentiation of adipocyte precursors in a serum-free medium is influenced by glucocorticoids and endogenously produced insulin-like growth factor-I
33. Impaired adipogenesis in insulin-like growth factor binding protein-1 transgenic mice
34. Expression of human insulin-like growth factor binding protein-3 in transgenic mice
35. In vivo actions of insulin-like growth factors (IGF-I) on brain myelination: Studies of IGF-I and IGF binding protein-1 (IG-FBP-1) transgenic mice
36. Insulin like growth factor I and the kidney